- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 20 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: V.273, T.274, W.275, E.276
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: R.64, K.127
- Chain B: P.2, R.3
Ligand excluded by PLIPSO4.7: 5 residues within 4Å:- Chain A: K.4, R.59, T.76, F.77, Q.78
Ligand excluded by PLIPSO4.8: 5 residues within 4Å:- Chain A: R.34
- Chain B: P.68, H.279
- Ligands: GOL.1, SO4.12
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain A: Y.74, S.88, N.142
- Ligands: GOL.1
Ligand excluded by PLIPSO4.10: 1 residues within 4Å:- Chain A: R.238
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain A: L.225, Y.227, D.228, F.229
Ligand excluded by PLIPSO4.12: 6 residues within 4Å:- Chain A: R.34, E.35
- Chain B: H.279, Q.280
- Ligands: GOL.1, SO4.8
Ligand excluded by PLIPSO4.13: 2 residues within 4Å:- Chain A: K.11, R.28
Ligand excluded by PLIPSO4.14: 9 residues within 4Å:- Chain A: G.19, S.20, F.21, S.22, K.39, L.41, Y.54, E.58, D.151
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: V.273, T.274, W.275, E.276
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain A: P.2, R.3
- Chain B: R.64, K.127
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain B: K.4, R.59, T.76, F.77, Q.78
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain A: P.68, H.279
- Chain B: R.34
- Ligands: GOL.16, SO4.27
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain B: Y.74, S.88, N.142
- Ligands: GOL.16
Ligand excluded by PLIPSO4.25: 1 residues within 4Å:- Chain B: R.238
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain B: L.225, Y.227, D.228, F.229
Ligand excluded by PLIPSO4.27: 6 residues within 4Å:- Chain A: H.279, Q.280
- Chain B: R.34, E.35
- Ligands: GOL.16, SO4.23
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain B: K.11, R.28
Ligand excluded by PLIPSO4.29: 9 residues within 4Å:- Chain B: G.19, S.20, F.21, S.22, K.39, L.41, Y.54, E.58, D.151
Ligand excluded by PLIP- 2 x JOZ: 3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)
JOZ.15: 9 residues within 4Å:- Chain A: L.16, V.24, A.37, L.87, S.88, Y.89, A.90, L.140, T.150
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.16, A:V.24, A:L.140
- Hydrogen bonds: A:S.88, A:A.90
JOZ.30: 9 residues within 4Å:- Chain B: L.16, V.24, A.37, L.87, S.88, Y.89, A.90, L.140, T.150
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.16, B:V.24, B:L.140
- Hydrogen bonds: B:S.88, B:A.90
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Medina, J.R. et al., Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery. ACS Med Chem Lett (2010)
- Release Date
- 2011-05-25
- Peptides
- PkB-like: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 20 x SO4: SULFATE ION(Non-functional Binders)
- 2 x JOZ: 3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Medina, J.R. et al., Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery. ACS Med Chem Lett (2010)
- Release Date
- 2011-05-25
- Peptides
- PkB-like: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A